Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | Filing |
| 2024-06-17 4:32 pm Purchase | 13D | MEREO BIOPHARMA GROUP PLC ADR MREO | Rubric Capital Management LP | 108,486,735 14.200% | 8,771,750 (+8.80%) | View |
| 2024-06-11 4:05 pm Purchase | 13D | XPERI INC XPER | Rubric Capital Management LP | 4,143,744 9.200% | 100,000 (+2.47%) | View |
| 2024-05-31 5:24 pm Unchanged | 13D | XPERI INC XPER | Rubric Capital Management LP | 4,043,744 9.000% | 0 (Unchanged) | View |
| 2024-05-31 11:08 am Unchanged | 13D | HERON THERAPEUTICS INC. HRTX | Rubric Capital Management LP | 26,713,503 17.700% | 0 (Unchanged) | View |
| 2024-04-16 2:58 pm Purchase | 13D | MEREO BIOPHARMA GROUP PLC ADR MREO | Rubric Capital Management LP | 99,714,985 14.220% | 10,100 (+0.01%) | View |
| 2024-02-21 2:00 pm Purchase | 13D | XPERI INC XPER | Rubric Capital Management LP | 4,043,744 9.300% | 307,525 (+8.23%) | View |
| 2024-02-14 10:28 am Purchase | 13D | XPERI INC XPER | Rubric Capital Management LP | 3,736,219 8.600% | 435,000 (+13.18%) | View |
| 2024-02-12 06:06 am Purchase | 13G | Arcutis Biotherapeutics Inc. ARQT | Rubric Capital Management LP | 6,644,530 7.040% | 6,644,530 (New Position) | View |
| 2024-02-12 06:06 am Purchase | 13G | GoodRx Holdings Inc. GDRX | Rubric Capital Management LP | 5,872,806 6.360% | 5,872,806 (New Position) | View |
| 2024-02-12 06:06 am Purchase | 13G | GOLAR LNG LTD GLNG | Rubric Capital Management LP | 6,506,757 6.210% | 154,001 (+2.42%) | View |
| 2024-02-12 06:06 am Purchase | 13G | Kiniksa Pharmaceuticals International plc KNSA | Rubric Capital Management LP | 2,907,501 8.210% | 2,907,501 (New Position) | View |
| 2024-02-12 06:06 am Sale | 13G | OVID THERAPEUTICS INC OVID | Rubric Capital Management LP | 5,315,969 7.520% | -1,512,096 (-22.15%) | View |
| 2024-02-12 06:06 am Sale | 13G | PAR PACIFIC HOLDINGS INC PARR | Rubric Capital Management LP | 1,199,749 1.980% | -1,849,251 (-60.65%) | View |
| 2024-02-12 06:06 am Purchase | 13G | SCPHARMACEUTICALS INC SCPH | Rubric Capital Management LP | 3,500,000 9.760% | 3,500,000 (New Position) | View |
| 2024-02-12 06:06 am Purchase | 13G | SUTRO BIOPHARMA INC STRO | Rubric Capital Management LP | 3,344,810 5.490% | 132,938 (+4.14%) | View |
| 2024-02-12 06:06 am Sale | 13G | DIGIMARC CORP DMRC | Rubric Capital Management LP | 0 0.000% | -1,214,593 (Position Closed) | View |
| 2024-02-12 06:06 am Purchase | 13G | Mativ Holdings Inc. MATV | Rubric Capital Management LP | 4,000,000 7.380% | 980,000 (+32.45%) | View |
| 2024-02-12 06:06 am Purchase | 13G | ANI PHARMACEUTICALS INC ANIP | Rubric Capital Management LP | 1,125,000 5.510% | 1,125,000 (New Position) | View |
| 2024-02-12 06:06 am Purchase | 13G | BGC GROUP INC BGC | Rubric Capital Management LP | 20,000,000 5.170% | 20,000,000 (New Position) | View |
| 2024-02-12 06:06 am Sale | 13G | CHIMERIX INC CMRX | Rubric Capital Management LP | 0 0.000% | -4,779,020 (Position Closed) | View |